Pre-earnings options volume in Soleno Therapeutics (SLNO) is 2.6x normal with calls leading puts 3:1. Implied volatility suggests the market is anticipating a move near 15.9%, or $10.45, after results are released. Median move over the past eight quarters is 3.1%.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- SLNO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Soleno not preannouncing Q3 sales ‘disappointing,’ says STAT’s Feuerstein
- Soleno Therapeutics rumor highlighted in Betaville alert
- Soleno Therapeutics Appoints Mark Hahn to Board
- Soleno Therapeutics appoints Hahn to its board of directors